DekaBank Deutsche Girozentrale
DOVA

DekaBank Deutsche Girozentrale’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21,800
Closed -$293K – 1176
2019
Q2 		$293K Buy
21,800
+8,500
+64% +$80.8K ﹤0.01% 974
2019
Q1 		$336K Buy
13,300
+2,400
+22% +$19.5K ﹤0.01% 980
2018
Q4 		$91K Sell
10,900
-2,400
-18% -$38.6K ﹤0.01% 1071
2018
Q3 		$336K Sell
13,300
-300
-2% -$7.14K ﹤0.01% 1002
2018
Q2 		$425K Hold
13,600
– – ﹤0.01% 939
2018
Q1 		$364K Buy
+13,600
New +$407K ﹤0.01% 915

Other funds holding DOVA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return